Ventricular Tachycardia

Clinical Trial Finder

Many patients with ventricular tachycardia are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center

Condition:   QT Interval Prolongation
Intervention:   Device: AliveCor handheld mobile ECG
Sponsors:   Indiana University;   Purdue University
Not yet recruiting - verified September 2016

Cardio‑Safety of Dihydroartemisinin‑Piperaquine and Pharmacokinetics of Piperaquine Amongst Pregnant Women in Tanzania

Conditions:   Malaria;   Pregnancy;   Cardiotoxicity;   Parasitemia
Interventions:   Drug: sulfadoxine-pyrimethamine (SP);   Drug: dihydroartemisinin-piperaquine (DHA-PQP)
Sponsors:   London School of Hygiene and Tropical Medicine;   Kilimanjaro Christian Medical Centre, Tanzania;   National Institute for Medical Research, Tanzania
Recruiting - verified June 2016

Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation

Condition:   Aortic Valve Disorder
Sponsors:   Institute for Clinical and Experimental Medicine;   Faculty Hospital Kralovske Vinohrady;   General University Hospital, Prague;   VZW Cardiovascular Research Center Aalst
Recruiting - verified September 2016

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device

Condition:   Heart Failure
Interventions:   Drug: Iobenguane I -123 Injection;   Device: Implantable Cardioverter Defibrillator;   Drug: Thyroid blocking
Sponsors:   GE Healthcare;   TFS Trial Form Support;   ICON plc
Recruiting - verified August 2016

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Condition:   Current or Recent History of Atrial Fibrillation
Interventions:   Drug: bucindolol hydrochloride;   Drug: metoprolol succinate
Sponsors:   ARCA Biopharma, Inc.;   Medtronic
Recruiting - verified September 2016

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Conditions:   Ventricular Tachycardia;   Atrial Fibrillation
Interventions:   Drug: Ethanol;   Procedure: Ablation
Sponsors:   Miguel X. Valderrabano, MD;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI);   The Methodist Hospital System
Recruiting - verified September 2016